List of Excipients in API temozolomide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing temozolomide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | TEMODAR | temozolomide | 0085-3004 | ALCOHOL | |
| Merck Sharp & Dohme LLC | TEMODAR | temozolomide | 0085-3004 | AMMONIA | |
| Merck Sharp & Dohme LLC | TEMODAR | temozolomide | 0085-3004 | ANHYDROUS LACTOSE | |
| Merck Sharp & Dohme LLC | TEMODAR | temozolomide | 0085-3004 | BUTYL ALCOHOL | |
| Merck Sharp & Dohme LLC | TEMODAR | temozolomide | 0085-3004 | FD&C BLUE NO. 2 | |
| Merck Sharp & Dohme LLC | TEMODAR | temozolomide | 0085-3004 | FERRIC OXIDE RED | |
| Merck Sharp & Dohme LLC | TEMODAR | temozolomide | 0085-3004 | FERRIC OXIDE YELLOW | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing temozolomide
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Lannett Company Inc | temozolomide | 0527-1777 | ALCOHOL |
| Lannett Company Inc | temozolomide | 0527-1777 | ALUMINUM OXIDE |
| Lannett Company Inc | temozolomide | 0527-1777 | ANHYDROUS CITRIC ACID |
| Lannett Company Inc | temozolomide | 0527-1777 | BUTYL ALCOHOL |
| Lannett Company Inc | temozolomide | 0527-1777 | CROSCARMELLOSE SODIUM |
| Lannett Company Inc | temozolomide | 0527-1777 | D&C YELLOW NO. 10 |
| Lannett Company Inc | temozolomide | 0527-1777 | FD&C BLUE NO. 1 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for temozolomide
Excipient focus: ALCOHOL
temozolomide drug variants containing ALCOHOL
temozolomide drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
temozolomide drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | temozolomide | 0527-1777 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | temozolomide | 23155-774 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
temozolomide drug variants containing AMMONIA
temozolomide drug variants not containing AMMONIA
Excipient focus: ANHYDROUS CITRIC ACID
temozolomide drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | temozolomide | 0527-1777 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS LACTOSE
temozolomide drug variants containing ANHYDROUS LACTOSE
temozolomide drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | temozolomide | 0527-1777 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | temozolomide | 23155-774 |
| Nivagen Pharmaceuticals Inc | temozolomide | 75834-132 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
temozolomide drug variants containing BUTYL ALCOHOL
temozolomide drug variants not containing BUTYL ALCOHOL
Excipient focus: CROSCARMELLOSE SODIUM
temozolomide drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | temozolomide | 0527-1777 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C YELLOW NO. 10
temozolomide drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | temozolomide | 0527-1777 |
| Sandoz Inc | temozolomide | 0781-2691 |
| AvPAK | temozolomide | 50268-761 |
| Amneal Pharmaceuticals LLC | temozolomide | 65162-801 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 1
temozolomide drug variants containing FD&C BLUE NO. 1
temozolomide drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
temozolomide drug variants containing FD&C BLUE NO. 2
temozolomide drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 3
temozolomide drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | temozolomide | 68382-751 |
| Zydus Lifesciences Limited | temozolomide | 70771-1092 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
temozolomide drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | temozolomide | 0527-1777 |
| AvPAK | temozolomide | 50268-761 |
| Amneal Pharmaceuticals LLC | temozolomide | 65162-801 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 5
temozolomide drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | temozolomide | 23155-774 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FD&C YELLOW NO. 6
temozolomide drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | temozolomide | 50268-761 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
temozolomide drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | temozolomide | 0085-3004 |
| Accord Healthcare Inc | temozolomide | 16729-048 |
| Physicians Total Care Inc | temozolomide | 54868-5348 |
| Areva Pharmaceuticals | temozolomide | 59923-712 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
temozolomide drug variants containing FERRIC OXIDE YELLOW
temozolomide drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | temozolomide | 0781-2691 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | temozolomide | 23155-774 |
| AvPAK | temozolomide | 50268-761 |
| Areva Pharmaceuticals | temozolomide | 59923-712 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
temozolomide drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | temozolomide | 0527-1777 |
| Sandoz Inc | temozolomide | 0781-2691 |
| Accord Healthcare Inc | temozolomide | 16729-048 |
| Camber Pharmaceuticals Inc | temozolomide | 31722-411 |
| ANI Pharmaceuticals Inc | temozolomide | 43975-252 |
| AvPAK | temozolomide | 50268-761 |
| Areva Pharmaceuticals | temozolomide | 59923-712 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
temozolomide drug variants containing GELATIN
temozolomide drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
temozolomide drug variants containing ISOPROPYL ALCOHOL
temozolomide drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: MANNITOL
temozolomide drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | temozolomide | 0527-1777 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing MANNITOL
Excipient focus: METHYL ALCOHOL
temozolomide drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | temozolomide | 0527-1777 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing METHYL ALCOHOL
Excipient focus: POLYSORBATE 80
temozolomide drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | temozolomide | 23155-774 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing POLYSORBATE 80
Excipient focus: POTASSIUM HYDROXIDE
temozolomide drug variants containing POTASSIUM HYDROXIDE
temozolomide drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE K30
temozolomide drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | temozolomide | 23155-774 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
temozolomide drug variants containing PROPYLENE GLYCOL
temozolomide drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | temozolomide | 16571-816 |
| Accord Healthcare Inc | temozolomide | 16729-048 |
| Rising Pharmaceuticals Inc | temozolomide | 64980-333 |
| Ascend Laboratories LLC | temozolomide | 67877-537 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
temozolomide drug variants containing SHELLAC
temozolomide drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | temozolomide | 16571-816 |
| Rising Pharmaceuticals Inc | temozolomide | 64980-333 |
| Ascend Laboratories LLC | temozolomide | 67877-537 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICA DIMETHYL SILYLATE
temozolomide drug variants containing SILICA DIMETHYL SILYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | temozolomide | 31722-411 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing SILICA DIMETHYL SILYLATE
Excipient focus: SILICON DIOXIDE
temozolomide drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | temozolomide | 0085-3004 |
| Lannett Company Inc | temozolomide | 0527-1777 |
| Sandoz Inc | temozolomide | 0781-2691 |
| Rising Pharma Holdings Inc | temozolomide | 16571-816 |
| Accord Healthcare Inc | temozolomide | 16729-048 |
| ANI Pharmaceuticals Inc | temozolomide | 43975-252 |
| AvPAK | temozolomide | 50268-761 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | temozolomide | 23155-774 |
| Camber Pharmaceuticals Inc | temozolomide | 31722-411 |
| Sun Pharmaceutical Industries Inc | temozolomide | 47335-890 |
| Nivagen Pharmaceuticals Inc | temozolomide | 75834-132 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
temozolomide drug variants containing SODIUM LAURYL SULFATE
temozolomide drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
temozolomide drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | temozolomide | 16571-816 |
| Sun Pharmaceutical Industries Inc | temozolomide | 47335-890 |
| Rising Pharmaceuticals Inc | temozolomide | 64980-333 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
temozolomide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
temozolomide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
temozolomide drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | temozolomide | 68382-751 |
| Zydus Lifesciences Limited | temozolomide | 70771-1092 |
| >Company | >Ingredient | >NDC |
temozolomide drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
Excipient focus: STEARIC ACID
temozolomide drug variants containing STEARIC ACID
temozolomide drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Nivagen Pharmaceuticals Inc | temozolomide | 75834-132 |
| >Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
temozolomide drug variants containing TARTARIC ACID
temozolomide drug variants not containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | temozolomide | 0527-1777 |
| Nivagen Pharmaceuticals Inc | temozolomide | 75834-132 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
temozolomide drug variants containing TITANIUM DIOXIDE
temozolomide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
temozolomide drug variants containing WATER
temozolomide drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
